NICE severity modifier: Not all QALYs are created equal
The UK’s National Institute for Health and Care Excellence (NICE) has published an update to its methods and processes for health technology assessment. The update follows a year-long review and includes a number of significant changes to how innovative...
Keeping it real #4 – Safety reporting in pre- to post-approval RWE studies
Missed our webinar about adding safety reporting to create continuous pre- to post-approval longitudinal digital real-world evidence studies? Watch it here! On 26th January 2022, Vitaccess hosted the fourth webinar in the “Keeping it real” series. Dr Mark...
Validating patient diagnosis in real-world studies
When is a patient a patient? Diagnosis “validation” is the part of the recruitment process for patient-/caregiver-reported studies where the eligibility of the prospective participant is verified. This usually includes confirmation that the patient does indeed have a...
Keeping it real #3 – Co-creating rare disease registries
Missed our webinar about co-creating rare disease registries? Watch it here! On Monday 15th November, Vitaccess hosted the 3rd webinar in the “Keeping it real” series. Dr Mark Larkin, CEO and Founder of Vitaccess; Dr Catherine Bottomley, Director of...
